American College of Chest Physicians has published new expert panel guidance around the use of low-dose CT.
There is new evidence-based guidance for the use of low-dose CT (LDCT) for lung cancer screening from the American College of Chest Physicians.
In an article published July 13 in CHEST, an expert panel from the College released 16 clinical recommendations based on a review of 75 studies. The new guidelines focus on the benefits, harms, and implementation of LDCT.
“The goal of these guidelines is to assist stakeholders with the development of high-quality screening programs and arm clinical providers with the information necessary to engage at-risk individuals in order to increase the number of screenings,” said lead author Peter Mazzone, M.D., MPH, FCCP. “Outlined in the recommendations is who should be screened and what that screening process should look like from the clinical side. For an individual patient, these guidelines highlight the importance of education to foster informed, value-based decisions about whether to be screened.”
Here is a summary of the 16 recommendations:
As a supplement to these published recommendations, CHEST and Thomas Jefferson University are offering a course dedicated to helping patients decide whether to undergo screening.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.